BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$421M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$387M |
| 3 |
Amazon
AMZN
|
+$331M |
| 4 |
Microsoft
MSFT
|
+$321M |
| 5 |
Salesforce
CRM
|
+$251M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.59B |
| 2 |
Citigroup
C
|
+$221M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$161M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$151M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$149M |
Sector Composition
| 1 | Technology | 12.42% |
| 2 | Financials | 9.95% |
| 3 | Communication Services | 9.82% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Healthcare | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1276
iShares MSCI Malaysia ETF
EWM
$245M
| $691K | ﹤0.01% |
22,173
-1,673
| -7% | -$52.2K |
|
|
BDN
1277
Brandywine Realty Trust
BDN
$796M
| $691K | ﹤0.01% |
40,935
+3,428
| +9% | +$57.9K |
|
1278
Graco
GGG
$14B
| $689K | ﹤0.01% |
15,241
+5,267
| +53% | +$238K |
|
|
CXP
1279
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $688K | ﹤0.01% |
30,280
+4,258
| +16% | +$96.7K |
|
1280
iShares MSCI Thailand ETF
THD
$238M
| $686K | ﹤0.01% |
8,341
-7,263
| -47% | -$598K |
|
|
MMP
1281
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $683K | ﹤0.01% |
9,884
-18,698
| -65% | -$1.29M |
|
|
RPAI
1282
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $683K | ﹤0.01% |
53,417
+5,453
| +11% | +$69.7K |
|
|
ROIC
1283
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $675K | ﹤0.01% |
35,229
-11,133
| -24% | -$213K |
|
|
COLO
1284
Global X MSCI Colombia ETF
COLO
$104M
| $674K | ﹤0.01% |
16,060
| – | – |
|
|
VG
1285
DELISTED
Vonage Holdings Corporation
VG
| $670K | ﹤0.01% |
52,015
-15,207
| -23% | -$196K |
|
|
MFA
1286
MFA Financial
MFA
$1.04B
| $669K | ﹤0.01% |
22,050
+12,457
| +130% | +$378K |
|
1287
News Corp Class B
NWS
$18.5B
| $668K | ﹤0.01% |
42,174
+2,729
| +7% | +$43.3K |
|
1288
Wolfspeed
WOLF
$386M
| $665K | ﹤0.01% |
16,007
-12,281
| -43% | -$511K |
|
1289
First Citizens BancShares
FCNCA
$24.7B
| $665K | ﹤0.01% |
1,649
+90
| +6% | +$36.3K |
|
1290
Service Corp International
SCI
$11.2B
| $664K | ﹤0.01% |
18,546
+10,924
| +143% | +$391K |
|
1291
Gentex
GNTX
$6.2B
| $663K | ﹤0.01% |
28,807
+18,003
| +167% | +$414K |
|
1292
Erie Indemnity
ERIE
$16.8B
| $650K | ﹤0.01% |
5,539
+2,876
| +108% | +$337K |
|
|
COHR
1293
DELISTED
Coherent Inc
COHR
| $642K | ﹤0.01% |
4,102
+1,774
| +76% | +$277K |
|
1294
West Pharmaceutical
WST
$18.5B
| $637K | ﹤0.01% |
6,417
+3,408
| +113% | +$338K |
|
1295
ROBO Global Robotics & Automation Index ETF
ROBO
$1.14B
| $633K | ﹤0.01% |
15,818
-9,237
| -37% | -$369K |
|
1296
Ormat Technologies
ORA
$5.51B
| $630K | ﹤0.01% |
11,853
-3,967
| -25% | -$211K |
|
1297
SITE Centers
SITC
$458M
| $629K | ﹤0.01% |
54,529
-280,050
| -84% | -$3.23M |
|
1298
Flex
FLEX
$21.6B
| $628K | ﹤0.01% |
59,073
+11,529
| +24% | +$123K |
|
1299
CNX Resources
CNX
$4.25B
| $625K | ﹤0.01% |
35,140
-105,017
| -75% | -$1.87M |
|
1300
Acadia Pharmaceuticals
ACAD
$4.16B
| $623K | ﹤0.01% |
40,796
+14,138
| +53% | +$216K |
|